Table 1 Patient characteristics
All | Weaned at LTACH | Not Weaned at LTACH | Alive in 90 Days | Expired in 90 Days | |
|---|---|---|---|---|---|
No. of Cases | 13,622 | 7046 | 6576 | 7668 | 5954 |
Time to LTACH | |||||
Mean | 19.6 | 19.1 | 20.2 | 19.2 | 20.2 |
25th percentile | 13.0 | 13.0 | 14.0 | 13.0 | 14.0 |
Median | 18.0 | 17.0 | 18.0 | 18.0 | 18.0 |
75th percentile | 24.0 | 23.0 | 25.0 | 23.0 | 25.0 |
Age | 70.6 | 68.7 | 72.7 | 68.6 | 73.2 |
Male | 50.4% | 50.2% | 50.7% | 49.3% | 51.9% |
Prior STACH LOS | 24.0 | 23.2 | 24.9 | 23.3 | 25.0 |
Prior STACH Procedures and Diagnoses | |||||
Dialysis | 15.2% | 13.2% | 17.5% | 12.4% | 18.9% |
PTCA | 1.6% | 1.4% | 1.7% | 1.6% | 1.5% |
CABG | 3.9% | 3.8% | 4.1% | 3.6% | 4.4% |
Valve Replacement | 2.8% | 2.6% | 3.0% | 2.4% | 3.3% |
Hypotension | 10.9% | 11.2% | 10.6% | 11.1% | 10.6% |
Thrombocytopenia | 15.9% | 15.5% | 16.3% | 15.0% | 17.0% |
Stroke | 13.5% | 15.0% | 12.0% | 14.1% | 12.7% |
Trauma | 9.8% | 10.7% | 8.8% | 10.2% | 9.3% |
Exlihauser Comorbidity | |||||
Congestive Heart Failure | 45.8% | 40.5% | 51.4% | 41.6% | 51.1% |
Cardiac Arrhythmias | 52.7% | 48.6% | 57.0% | 49.3% | 57.0% |
Valvular Disease | 12.3% | 10.6% | 14.2% | 10.7% | 14.4% |
Pulmonary Circulation Disorders | 15.4% | 13.6% | 17.2% | 14.6% | 16.4% |
Peripheral Vascular Disorders | 12.1% | 11.5% | 12.7% | 11.2% | 13.3% |
Hypertension, Uncomplicated | 39.3% | 42.7% | 35.7% | 43.0% | 34.7% |
Paralysis | 8.9% | 10.3% | 7.5% | 10.1% | 7.4% |
Other Neurological Disorders | 44.3% | 44.6% | 44.1% | 44.7% | 43.8% |
Chronic Pulmonary Disease | 48.3% | 45.2% | 51.5% | 47.3% | 49.5% |
Diabetes, Uncomplicated | 30.0% | 30.3% | 29.7% | 29.7% | 30.3% |
Diabetes, Complicated | 8.9% | 8.3% | 9.6% | 8.2% | 9.8% |
Hypothyroidism | 13.9% | 13.8% | 14.0% | 13.3% | 14.5% |
Renal Failure | 30.2% | 26.3% | 34.3% | 25.9% | 35.7% |
Liver Disease | 9.1% | 9.0% | 9.3% | 8.7% | 9.7% |
Peptic Ulcer Disease Excluding Bleeding | 1.7% | 1.7% | 1.7% | 1.8% | 1.6% |
AIDS/HIV | 0.4% | 0.4% | 0.5% | 0.4% | 0.5% |
Lymphoma | 1.1% | 1.0% | 1.2% | 0.8% | 1.4% |
Metastatic Cancer | 1.4% | 0.9% | 2.1% | 0.8% | 2.3% |
Solid Tumor Without Metastasis | 3.7% | 2.6% | 4.9% | 2.4% | 5.4% |
Rheumatoid Arthritis/Collagen Vascular | 3.7% | 3.9% | 3.4% | 3.8% | 3.5% |
Coagulopathy | 19.9% | 19.3% | 20.5% | 18.6% | 21.5% |
Obesity | 21.3% | 23.4% | 19.0% | 24.0% | 17.7% |
Weight Loss | 42.8% | 40.9% | 44.8% | 40.5% | 45.7% |
Fluid and Electrolyte Disorders | 78.7% | 78.6% | 78.9% | 78.4% | 79.2% |
Blood Loss Anemia | 1.8% | 1.8% | 1.7% | 1.7% | 1.8% |
Deficiency Anemia | 4.1% | 4.5% | 3.7% | 4.4% | 3.7% |
Alcohol Abuse | 5.8% | 6.9% | 4.6% | 6.7% | 4.7% |
Drug Abuse | 3.2% | 4.3% | 2.0% | 4.1% | 2.1% |
Psychoses | 3.1% | 3.8% | 2.4% | 3.6% | 2.5% |
Depression | 11.6% | 13.1% | 10.0% | 13.3% | 9.5% |
Hypertension, Complicated | 28.4% | 25.0% | 32.1% | 24.4% | 33.5% |
Number of Elixhauser comorbidities (mean) | 6.0 | 5.9 | 6.2 | 5.9 | 6.2 |